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Abstract. Chagas disease affects millions of people, and it is a major cause of death in 15 
Latin America. Prevention and development of an effective treatment for this infection 16 
can be favored by a more thorough understanding of T. cruzi interaction with the 17 
microbiome of vectors and hosts. Next-generation sequencing technology vastly 18 
broadened the knowledge about intestinal bacteria composition, showing that 19 
microbiota within each host (triatomines and mammals) is composed by high diversity 20 
of species, although few dominant phyla. This fact may represent an ecological balance 21 
that was acquired during the evolutionary process of the microbiome-host complex, and 22 
that serves to perpetuate this system. In this context, commensal microbiota is also 23 
essential to protect hosts, conferring them resistance to pathogens colonization. 24 
However, in some situations, the microbiota is not able to prevent infection but only 25 
modulate it. Here we will review the role of the microbiota on the parasite-vector-host 26 
triad with a focus on the kinetoplastida of medical importance Trypanosoma cruzi. 27 
Novel strategies to control Chagas disease based on intestinal microbiome will also be 28 
discussed. 29 
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1. Introduction 37 
 38 
The intestinal ecosystem is an environment in which biological and biochemical 39 
interactions occur at various hierarchical levels, connecting microbial communities and 40 
their hosts. [1, 2] Studies of fecal samples revealed that the microbota from a wholesome 41 
intestine is an intricated ecological community comp sed of trillions of 42 
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microorganisms, from viruses to unicellular eukaryotes.[3] However, in this article, we 43 
will use the term microbiota to refer only to the population of bacteria of an organism. 44 
The intestinal microbiota is highly dynamic, it varies over time and is modulated 45 
by environmental conditions (use of antibiotics, lifestyle, diet and hygiene preferences, 46 
metabolic dysfunction, immunodeficiency and hyper immunity).[4]The application of 47 
new high-performance methodologies for analysis of bacterial species, such as the new 48 
generation sequencing (NGS) of 16S rRNA, revolutionized the knowledge about the 49 
intestinal microbiome. [5] It is now known that about 1000 bacterial species inhabit the 50 
human adult intestine; however, the predominant genera are Lactobacillus, 51 
Bifidobacterium, Bacteroides, Eubacterium, Clostridium, Ruminococcus, 52 
Peptostreptococcus, and Peptococcus.[ 5] Despite the large number of distinct species, 53 
they belong to a relatively small number of phyla, especially  Bacteroidetes and 54 
Firmicutes. [6] 55 
In healthy hosts, the presence of this microbiota cntributes to the prevention of 56 
pathogen colonization.[7] Additionally, it has an important impact on various aspects of 57 
the hosts physiology and metabolism; such as, protecti n of intestinal epithelium, 58 
digestion of host nutrients, production of vitamins and hormones, and regulation of 59 
immune responses, modulating the expression of immunological mediators and the 60 
recruitment of certain cell populations.[ 8, 9] 61 
Changes in microbiota composition usually have a direct effect on parasitic 62 
infection, in part because parasites and bacteria met bolize substrates interactively and 63 
secrete products that affect each other, interfering with the survival and physiology of 64 
both. [10 ]Likewise, the microbial community constitution is an extremely important 65 
factor for host immune responses: imbalance between th  microbiota and the immune 66 
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system may alter the host's homeostasis and lead to greater disease susceptibility, and 67 
therefore dictate the success of the intestinal pathogens. 68 
Published data demonstrate that the intestinal microb ota usually has a deep 69 
influence on the parasite-host relationship.[11] It is well known that intestinal microbiota 70 
composition is determinant for some parasites pathogenicity, as described for 71 
Entamoeba histolytica,[12] Trichuris muris,[13] Schistosoma mansoni,[14] Eimeria 72 
falciformis,[ 15] Eimeria ovinoidalis, [16] Ascaris lumbricoides,[ 17] and Giardia lamblia. 73 
[18] 74 
On the other hand, this microbiota can reduce the damages of other infectious 75 
agents, such as Cryptococcus neoformans,[19]  Strongyloides venezuelensis, [20] and 76 
almost all enteropathogenic bacteria (Clostridium difficile, Clostridium perfringens, 77 
Escherichia coli, Pseudomonas aeruginosa, Salmonella typhimurium, Shigella xexneri 78 
and Vibrio cholerae). [21, 22, 23] In few reported cases - Raillietina cesticillus,[24 ]Isopora 79 
suis,[25 ]and Trichuris trichiura [17]- the microbiota composition appear not to influenc  80 
the outcome of the disease. 81 
T. cruzi is the etiological agent of Chagas disease, th  most important parasitic 82 
disease in the Americas, affecting approximately 6 to 8 million people and causing 83 
around 12,000 deaths per year. [26]Little is known about the modulation of T. cruzi 84 
infections by the intestinal microbiota, in insects or vertebrate hosts. Approximately 85 
30% of infected individuals will develop cardiac, digestive or neurological changes 86 
during the chronic phase. Chagas disease pathogenesis has not been fully elucidated, 87 
and different theories try to explain it, such as parasite persistence and 88 
autoimmunity.[27]This fact contributes to the difficulty in developing an effective 89 
treatment. In this review, we will summarize the current knowledge on microbiome of 90 
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T. cruzi invertebrate and vertebrate hosts, highlighting new approaches and research 91 
gaps in this field (Figure 1).  92 
 93 
Figure 1. Multi-effects of the intestinal microbiota on the vector-parasite-host 94 
triad. In healthy, non-infected, vectors and hosts, the resident microbiota will play an 95 
important role in the maintenance of homeostasis (eubiosis). During T. cruzi infection, 96 
the parasite and bacteria metabolize substrates intractively and secrete products that 97 
affect each other and interfere in the survival andphysiology of the host (dysbiosis).   98 
 99 
2. Gut microbiota in parasite-vector interface 100 
Hemiptera insects began to inhabit our planet about 400 million years ago, being 101 
favored by the emergence of vascular plants, whose phloem served as their food source. 102 
Throughout the evolutionary process, adaptations of the oral apparatus of these 103 
arthropods allowed the acquisition of new feeding habits, such as hematophagy. [28, 104 
29]Triatomines (Hemiptera: Reduviidae), popularly know  as kissing bugs, are life-long 105 
obligatorily hematophagous arthropods which feed on various animals, mainly 106 
mammals. During hematophagy, several microorganisms can reach triatomines 107 
alimentary tract and begin its colonization. 108 
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In recent years, triatomines microbiota has been evaluated by NGS, showing that 109 
the ecological diversity of its microbiome is low but dynamic, changing according to 110 
genera and gender, development stages origin, and blood sources.[30, 31, 32] The 111 
assessment of T. brasiliensis and T. pseudomaculata microbiome by denaturing gradient 112 
gel bands sequencing revealed their microbiota was mo tly composed by Proteo- and 113 
Actinobacteria; being Serratia the predominant genus. [33]Analyzes of the 16S rRNA 114 
gene of the intestinal microbiota of Triatoma maculata and Rhodnius pallescens 115 
captured in the same locality of Colombia, showed the distinct composition of bacteria 116 
community. In R. pallescens, Williamsia and Kocuria (orders Corynebacteriales and 117 
Actinomycetales, respectively) were the most prevalnt genera, while in T. maculate, 118 
Dietzia, Aeromonas and Pelomonas (orders Actinomycetales, Aeromonadales and 119 
Burkholderiales, respectively) were predominant.[30]Another study confirmed that 70% 120 
of Triatoma diminiata microbiome was composed by bacteria from orders Bacillales, 121 
Actinomycetales, Enterobacteriales and Burkholderiales. However, the predominating 122 
bacteria in bugs fed on dogs was Burkholderiales, in those fed on humans was 123 
Bacillales, and for those fed on porcupine was Enterobacteriales. [31]Interestingly, 124 
Rodríguez-Ruano et al., [34] showed that the microbiome composition is particularly 125 
determined by host species, receiving less influence of locality and environment.  126 
Following a blood meal, kissing bugs can also ingest the protozoa T. cruzi. Once 127 
inside the insect gut, T. cruzi have to invade surrounding tissues of the vector and 128 
transform to epimastigote forms and later, in infective metacyclic forms, which are 129 
eliminated with excreta and can achieve the host bloodstream through the bite site. 130 
During this journey, T. cruzi and the resident microbiota maintain an intimate 131 
interaction looking for a balance for the establishment of both.  132 
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Independently of gut microbiota composition, most of T. cruzi is destructed in 133 
the first hours of vector infection. [35]After that, parasite-microbiota interaction is 134 
essential to control T. cruzi amount. In vitro experiments showed that bacterial clusters 135 
can adhere to T. cruzi surface through D-mannose recognizing fimbriae andlea  to 136 
parasite lysis. [35]Furthermore, a control of parasite replication is al o orchestrated by 137 
the local bacteria.[36]Thus, to provide continuity to its life cycle in the digestive tract of 138 
triatomines and increase their chances of reaching a new host, T. cruzi needs to 139 
overcome the microbiota trypanolytic activity. The interaction between parasite and 140 
microbiota could vary among different vectors. As an example, T. cruzi Dm28c strain 141 
when stimulated induce antibacterial activities in Rhodnius prolixus, resulting in fewer 142 
bacteria and higher parasitemia. However, the T. cruzi Y strain is not able to produce 143 
the same effects, being inefficient in the establishment of the infection in the vector.[37] 144 
Vectors infected with T. cruzi synthesize antimicrobial peptides, such as 145 
defensins and prolixicin, to control the expansion of the new invader, in a strain-146 
dependent manner. [38]These bioactive molecules may also affect the resident 147 
microbiota richness,[34]and consequently, benefit or impair parasite survival. For 148 
example, the use of a selective inhibitor of NF-κb in R. prolixus modulated the gene 149 
expression of defensins, increasing the microbiota and reducing T. cruzi population. 150 
[39]Furthermore, the knockdown of the antimicrobial product from Triatoma infestans 151 
midgut (TiAP) increased by 600 times the amount of gut bacteria and, consequently, 152 
reduced the number of T. cruzi epimastigotes.[40]So, TiAP controls microbiota growth, 153 
contributing to T. cruzi establishment in the vector. Similarly, a Kzal-type inhibitor 154 
from the midgut of R. prolixus (RpTI) is involved in microbiota regulation and its 155 
silencing with RNA interference technology resulted in higher bacterial loads.[41]In 156 
contrast, Díaz et al.[42]reported that triatomines challenged with T. cruzi have their 157 
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microbiome altered in a species-specific manner; haboring a more diverse bacterial 158 
community than the negative controls. The significance of this increase in diversity 159 
must be better investigated. 160 
 161 
3. Gastrointestinal microbiota in the parasite-mammal interface 162 
Novel bioluminescence imaging systems have evidenced th  persistence of T. 163 
cruzi infection in the GIT (gastrointestinal tract) during the acute and chronic Chagas 164 
disease.[43, 44]The persistence of T. cruzi in the gut could contribute to the development 165 
of GIT disorders, notably megacolon and/or megaesophagus, resulting in altered 166 
peristaltic movements, dysphagia and pain. It is believ d that the chronic 167 
gastrointestinal symptoms of Chagas disease are a consequence of the destruction of the 168 
myenteric neurons by the parasite. [45 ]Furthermore, continuous migration of T. cruzi 169 
from the GIT to other organs such as the heart has been suggested, indicating that the 170 
intermittent traffic of parasites can be involved in chronic Chagas cardiomyopathy.[ 44, 171 
46 ] 172 
In the gut, T. cruzi may interact with thousands of commensal bacteria, but little 173 
is known about this ecological relationship. Apparently, an indirect contact should occur 174 
between parasite-bacteria, since T. cruzi is preferentially found in the muscularis 175 
externae of GIT.[ 47 ]The impact of this protozoa on microbiota profile and metabolome 176 
were characterized in an immunocompetent murine model, [48 ]in which T. cruzi 177 
disrupted fecal microbiome and caused biochemical alterations in a synchronized 178 
manner. For example, variations in linoleic acid metabolism could be observed. 48 179 
Linoleic acid metabolism has been associated with an important immune-modulating 180 
response, affecting T cell recruitment and cytokines production in the colon, [49 ]which 181 
could favor T. cruzi persistence. 182 
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Researches on germ-free mice infected with T. cruzi have been performed to 183 
characterize immunoregulation and clinical evolution f Chagas disease in this 184 
experimental model. Silva et al., [50]showed that the lack of the natural microbiome 185 
negatively influenced parasitemia intensity, mortality rate, spleen size, and cardiac 186 
damage. However, the same findings were not obtained by Duarte et al.,[51]in whose 187 
study the infection outcome did not alter significantly between control and germ-free 188 
mice, despite a higher production of inflammatory cytokines in the first group.  189 
The role of specific species of bacteria on Chagas disease immunomodulation 190 
was also evaluated in germ-free mice.[ 52 ]Mono-association of T. cruzi with E. coli, E. 191 
faecalis, B. vulgatus or Peptostreptococcus sp produced a Th1 immune response, higher 192 
levels of IgGs and increased survival rate. Interesingly, these tested bacteria are 193 
predominant in the indigenous microbiota, but there is no evidence that this population 194 
group is more resistant to the development of Chagas disease clinical manifestations.[ 53 195 
]In this respect, characterization of the microbiome in coprolites and colon of a chagasic 196 
pre-Columbian Andean mummy revealed that paleofeces were constituted 197 
predominantly by Firmicutes, with Clostridium spp. and Turicibacter spp. representing 198 
the most abundant bacterial genera. [54] 199 
Since gut microbiome depends on intestinal health, it is expected its impairment 200 
during Chagas disease, regardless of ancestry. Quantitative and qualitative analysis of 201 
the microbiota in chagasic megaesophagus and health sophagus showed a more 202 
elevated bacterial concentration and variability inchagasic patients, with a 203 
predominance of the aerobic gram-positive bacteria St eptococcus sp and the anaerobic 204 
Veillonella. [55]In the proximal jejunum of patients with megacolon, it was observed an 205 
overgrowth of facultative and strict anaerobes microorganisms, which returns to 206 
normality after surgical treatment.[56] 207 
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Dysbiosis in Chagas disease may also be associated wi h the emergence of 208 
secondary diseases. The proliferation of certain bacteri  in the esophageal lumen can 209 
cause pulmonary infections, dysplasia of the esophageal mucosa and 210 
cancer.[55]Individuals with a more advanced stage of esophageal dilation have elevated 211 
concentrations of Staphylococcus sp, Corynebacterium sp, Peptostreptococcus sp and 212 
Veillonella sp, bacteria that are capable of reducing nitrate into nitrites, which have been 213 
associated with the formation of proven esophageal carcinogens nitrosamines. [57, 58] 214 
 215 
4. Novel approaches based on intestinal microbiota to control chagas disease 216 
In triatomines, obligate bacterial symbionts are essential to obtain some nutrients 217 
from the blood-diet, without which several aspects of insect physiology would be 218 
compromised, notably its development. [59, 60]It is noteworthy to note that the 219 
availability of nutrients affects the vector, the T. cruzi population density and the 220 
number of metacyclic tripomastigotes in the rectum. [61] Therefore, bacterial 221 
communities in the insect gut are essential for T. cruzi survival.[62]Interestingly, new 222 
methodologies are being developed to facilitate the c aracterization of triatomines gut 223 
ecosystem: RADseq-based analysis was used to disclose mixed DNA from vectors 224 
abdomens, enabling the determination of T. cruzi DTUs, microbial diversity, and blood 225 
meal source. [63] 226 
In this sense, it is quite plausible to think about novel strategies of T. cruzi 227 
transmission blocking and vector control based on its microbiota (Figure 2), since the 228 
traditional strategies seem to be ineffective, such as the use of insecticides. [64]Studies 229 
employing antibiotic treatment, specific antibodies or rearing gnotobiotic lines has 230 
brought important information about the role of intestinal bacteria on 231 
parasites.[65]Triatomine engineering aiming antimicrobial peptides reduction results in 232 
10 
 
increased bacterial load in the midgut and decreased T. cruzi parasitemia, influencing 233 
vector competence. [40] It is noted that production of genetically-modified vectors that 234 
interferes in microbial colonization is an advantageous strategy because it can be 235 
applied to all species of triatomines and impairs T. cruzi survival. Intestinal microbiota 236 
can also be modified by RNA interference-based technologies to control vectors: E. coli 237 
expressing specific dsRNAs for Rhodnius prolixus heme-binding protein and catalase 238 
affected mortality, molting and oviposition rates.[66]Other examples of promising 239 
alternatives to control vector infection are the usof bacteria with trypanocidal activity, 240 
such as Serratia, a commensal of triatomine guts that deregulates T. cruzi mitochondrial 241 
activity.[67] and the treatment of R. prolixus with physalin B, a natural secsteroid that 242 
promotes an increase in gut bacterial microbiota and significantly decreases the number 243 
of T. cruzi. [68] 244 
In mammals, commensal microbes interact with parasites that cohabitate and 245 
change the progression of the infection. Recent discoveries, [44; 43]show the intestine as 246 
a preferential site of T. cruzi, where local bacteria can act directly on the parasite and 247 
determine its infectivity. Furthermore, infection can also be modulated at distance. In 248 
both cases, the mutualism developed between parasites and microbiota seems to be 249 
associated with subclinical manifestations. [69]Therefore, the administration of 250 
prebiotics and probiotics to replace the resident microbiota can be promising, since the 251 
newly introduced bacteria will compete with the parasites for nutrients and space as 252 
well as stimulate the host’s immune system to react against infection.[70]Identification 253 
of which prebiotics/probiotics can boost protective immune responses can contribute to 254 
the success of future treatments. In this respect, oral and intraperitoneal inoculation of L. 255 
casei in NIH mice resulted in reduction of circulating parasites.[71] 256 
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Associated to this, specific diets may contribute to the growth of the microbiota 257 
species of interest that diminish the virulence andsurvival of the parasites.[69]High fat 258 
diet and protein deficiency seems to increase parasitemia and leucocyte infiltration in 259 
cardiac tissue. [72, 73] Such aspects become more evident when analyzed in germ-free 260 
mice. Cintra et al. [74]showed that protein deficiency resulted in a more severe Chagas 261 
disease in germ-free mice than the controls. Santos et al. [75]observed that the effect of a 262 
deficient fatty acid diet on a germ-free T. cruzi-infected model resulted in a larger 263 
amount of tripomastogotes per ml of blood and a lower survival rate.  264 
New insights about which mechanisms are involved in parasite-microbiota 265 
interaction are also needed. For example, the role of inflammasome should be better 266 
elucidated, since its activation controls microbial dysbiosis, protecting the organisms 267 
from autoinflammatory responses. However, parasites can reduce inflammasome 268 




Figure 2. Challenges to consolidate the knowledge about the role of the intestinal 271 
microbiota on the vector-parasite-host triad. Gaps in research need to be fulfilled to 272 
determine the real importance of the intestinal microbiota on T. cruzi infection. Novel 273 
approaches are essential to elucidate crucial issues.  274 
 275 
5. Conclusions 276 
Reports on parasites and microbiota interaction have become extremely common 277 
because of next-generation sequencing technology. However, a bias may have been 278 
created because of the possibility of lack of DNA sequencing from less abundant, but of 279 
pathological importance, bacteria populations. Furthermore, expanding knowledge 280 
about Archae diversity [77]and its interaction with the microbiota can evidenc  new 281 
aspects of the complex GIT ecosystem. Also, the inclusion of virus, fungi and, 282 
eukaryotes should be considered in the next studies.  283 
Importantly, some results may be valid for certain ecological conditions, but not 284 
to others. So, field-based research can bring to light nformation that could not be 285 
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obtained in controlled lab-models. Another research line that should be further explored 286 
in order to address how intestinal bacteria are acquired and maintained in hosts and 287 
which combination of bacteria could be required to pr tect against T. cruzi infection. 288 
[78]Understanding the mechanisms that interfere in infection progression is essential. 289 
Experiments with T. cruzi infected animals treated with antibiotics and recolonized with 290 
specific bacteria can provide important information f how these microorganisms 291 
modulate the infection. Gene exchange among microbiome-parasite-hosts is a 292 
possibility that should be considered in this intimate relationship.  293 
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• Intestinal microbiota has a deep influence on the parasite-host 
relationship 
• In triatomines, gut microbiota can benefit or impair T. cruzi survival  
• In mammals, T. cruzi-associated dysbiosis affects immune responses 
• Novel approaches based on gut microbiota can be proposed to control 
Chagas disease  
 
 
 
